DIVISION OF CLINICAL PSYCHOLOGY
FACULTY FOR ONCOLOGY AND PALLIATIVE CARE
TUESDAY 25 MAY 2021, VIRTUAL WEBINAR
KEYNOTE SPEAKERS
Dr. Lynn Calman
Associate Professor and Deputy Director, Macmillan Survivorship Research Group
Dr. Lynn Calman is an Associate Professor and Deputy Director of the Macmillan Survivorship Research Group [MSRG], School of Health Sciences, University of Southampton. Lynn has a clinical background in nursing and has held academic positions at the Universities of Glasgow and Manchester, before taking up her role in Southampton in 2012.
Lynn had led and collaborated on a number of major research studies in psychosocial oncology and leads her own research programme focusing on people living with advanced cancer.
Lynn is a member of the member of the National Cancer Research Institute (NCRI) Lung Cancer Group (CSG) and Living with and Beyond Cancer Group. Lynn is a member of the UK Psychosocial Oncology Society (BPOS) Executive.
Janice Preston
Macmillan Cancer Care, Head of Partnerships, Scotland and Northern Ireland
Janice trained as a nurse, specialising in cancer nursing. She worked in the Beatson Oncology Centre for 17 years, 10 of which were specialising in chemotherapy delivery and redesign, involving people with cancer to help ensure we delivered person centred improvements.
Janice moved to Macmillan as the West of Scotland Development Manager in 2004 where she was proactive in supporting psychosocial networks and roles. and has changed roles a number of times, whilst remaining in the partnership investment area of Macmillan. She took on Head of Service role for Scotland 6 years ago, with a change to Head of Partnership for Scotland and NI in 2020.
Janice is currently leading workstreams in Macmillan on embedding holistic needs assessment and developing propositions around psychological support. Her main areas of interest are around innovation and large scale spread and around how digital technologies can empower the citizen in their care.
Alex King
Consultant Clinical Psychologist
'BPS SIGOPAC Guidance, a year on: A Clinical Service Perspective'
Alex King is a Consultant Clinical Psychologist at Imperial College Healthcare NHS Trust and lead author of the Faculty of Oncology & Palliative Care guidance on Psychological insights for cancer services recovery planning.
PANEL DISCUSSION
Barbara Hibbert
I was first diagnosed with stage 4 bowel cancer, which had metastasized to the liver, in 2014. Since then I have had three lots of major surgery, gone through all the standard of care chemotherapy, been declared cured twice, and given 6-9 months to live three times. It’s been a rollercoaster!
I’m now on a phase 1 clinical trial at the Christie, in Manchester, and although it’s early days, things are going well so far. When I was first diagnosed, at the age of 57, the odds on surviving five years were less than 10%. At one point I thought I might not see my granddaughter born, but she is about to start school in September.
I continue to work, although not as much as I used to, on various projects related to history teaching. I am also involved with work as a patient representative and volunteer with various projects related to cancer and end-of-life care, including Bowel Cancer UK, Yorkshire Cancer Research, Bowel Cancer Intelligence UK and BCIP. I am keen to provide a voice for those, like me, who are living well with a dire prognosis. I’m fitter than I’ve ever been, through losing three stone or so (although the weight crept back on a bit during lockdown) taking more exercise, and cutting my drinking dramatically.
Dr. Susana Banerjee MBBS MA PhD FRCP
Consultant Medical Oncologist, Research Lead Gynaecology Unit
Dr. Susana Banerjee (MBBS MA PhD FRCP) is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit at the Royal Marsden, London, UK. She is also Reader in Women’s Cancers at the Institute of Cancer Research. Dr. Banerjee specialises in ovarian cancer and the systemic treatment of endometrial and cervical cancers.
She graduated with a 1st class from St. John's College, University of Cambridge. She gained a PhD from the Institute of Cancer Research, University of London and completed specialist training at The Royal Marsden.
Dr. Banerjee has been involved in several national and international specialist groups including the National Cancer Research Institute (NCRI), European Organization for Research and Treatment of Cancer (EORTC) Executive Steering Committee for Gynaecological Cancers. She was the Track Chair for Gynaecological Cancers at ESMO Congress 2018, Scientific Co-Chair for ESMO Asia 2018 and is co-chair of the ESMO Gynaecological Cancers congress 2021.
She serves on the European Society of Medical Oncology (ESMO) Executive Board as Director of Membership. She is chair of the ESMO Resilience Task Force. She leads the ESMO Resilience Task Force Survey series assessing wellbeing since COVID-19 in oncology professionals.
Dr. Banerjee is Chief Investigator of the academic-sponsored COVID-NOW (The COVID-19 Work Ability and Wellbeing NHS Oncology Workforce Study) national study. Dr. Banerjee is an author of over 140 peer-reviewed publications and is actively involved in clinical trials and translational research. Dr Banerjee is UK Chief Investigator and Principal Investigator at the Royal Marsden for multiple national and international clinical trials.
BPS 2021
Managed by:
KC Jones conference&events Ltd